Using CD44 as a biomarker to select breast cancer stem cells for single-cell sequencing, we have demonstrated that CD44GFP-high breast cancer MCF7 cells consist of multiple subpopulations with marked heterogeneity28. This evidence concerns the gene CD44 and breast carcinoma.